✦ LIBER ✦

Loss of heterozygosity of the polymorphic PIG3 microsatellite with low frequency in de novo acute myeloid leukemias

✍ Scribed by Nomdedéu, J F; Perea, G; Estivill, C; Lasa, A; Brunet, S; Aventín, A; Sierra, J

Book ID: 110055905
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 81 KB
Volume: 18
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403379

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensive induction chemotherapy with re

Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia

✍ Jiazhuo Liu; Yingchang Mi; Mingwei Fu; Wenjuan Yu; Ying Wang; Dong Lin; Shougeng 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 2 views

Prognostic significance of FLT3 internal

Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapy

✍ Boissel, N; Cayuela, J M; Preudhomme, C; Thomas, X; Grardel, N; Fund, X; Tigaud, 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 216 KB

Therapeutic strategy of untreated de nov

Therapeutic strategy of untreated de novo acute myeloid leukemia in the elderly: the efficacy of continuous drip infusion with low dose cytarabine and etoposide

✍ Hisashi Tsurumi; Nobuhiro Kanemura; Takeshi Hara; Senji Kasahara; Toshiki Yamada 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 262 KB

Rarity of dominant-negative mutations of

Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia

✍ Carapeti, M; Soede-Bobok, A; Hochhaus, A; Sill, H; Touw, I P; Goldman, J M; Cros 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 268 KB

Long-term survival data from a phase 3 s

Long-term survival data from a phase 3 study of Filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia

✍ Heil, G; Hoelzer, D; Sanz, M A; Lechner, K; Noens, L; Szer, J; Ganser, A; Matcha 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

Polymorphisms in transporter and phase I

Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups

✍ Phillip Müller; Nava Asher; Maya Heled; Sara Bar Cohen; Angela Risch; Deborah Ru 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Drug metabolism/disposition and transporter genes may influence predisposition or prognosis of AML (acute myeloid leukemia) patients. We analyzed polymorphisms in 3 transporters and 4 drug metabolism genes in 293 Israeli individuals (112 AML patients and 181 controls). We analyzed: ABCC3 (MRP3) C-21